News
Investors
Investor Summary
Investor Summary
Analysts
FAQ
News & Events
Press Releases
Investor Presentations
Pfenex Form 8937
IR Calendar
Email Alerts
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Governance
Governance Documents
Corporate Responsibility
Corporate Responsibility
Environmental
Social
Governance
Twitter Guidelines
ESG Annual Report
Nasdaq: LGND
Home
Investors
About
Overview
Management Team
Board of Directors
Careers
Contact
Portfolio Summary
Overview
Marketed Products
Portfolio
Royalty Table
Partners and Licensees
Technologies
Overview
OmniAb
Captisol
Icagen
Protein Expression Platform
Licensing Opportunities
Business Development
Press Releases
Navigation
Press Releases
Investor Presentations
Pfenex Form 8937
IR Calendar
Email Alerts
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All News
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Ligand to Report Fourth Quarter Results on February 13th
January 23, 2013
Ligand Receives Equity Milestone Payment from Retrophin
January 9, 2013
« Previous
1
2
3
Twitter
